Mighty Therapeutics
Needham, US · 1 known investors
Find your way into Mighty Therapeutics
134 people in our graph share verified history with the Mighty Therapeutics team — schools, employers, funds. One of them is your warm intro.
Florin Mihocunlockedknows Reenie McCarthy · together at Freight Farms (overlapped)
×4knows the team · via Bates College
×7knows the team · via University of Pennsylvania Carey Law School
Mighty Therapeutics is a biopharmaceutical company developing mitochondria-targeted medicines to treat mitochondrial dysfunction in rare genetic mitochondrial diseases and common age-related conditions. Its pipeline spans rare genetic diseases, ophthalmic disorders, and neurological conditions, and it delivered the first approved therapy for Barth syndrome.
Founders & leadership
RM
Reenie McCarthyinCEOReenie McCarthy spent over 20 years as a venture capital investor in biotechnology at Morningside before becoming CEO of Mighty Therapeutics, a biopharmaceutical company developing mitochondria-targeted medicines for rare genetic and age-related diseases.
Investors · 1
In the news
Frequently asked questions
- What does Mighty Therapeutics do?
- Mighty Therapeutics is a biopharmaceutical company developing mitochondria-targeted medicines to treat mitochondrial dysfunction in rare genetic mitochondrial diseases and common age-related conditions. Its pipeline spans rare genetic diseases, ophthalmic disorders, and neurological conditions, and it delivered the first approved therapy for Barth syndrome.
- Who are Mighty Therapeutics's investors?
- Mighty Therapeutics's investors include K2 HealthVentures.
- Where is Mighty Therapeutics headquartered?
- Mighty Therapeutics is headquartered in Needham, US.